Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Kerneis

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
European Journal of Preventive Cardiology|February 14, 2025
A family-based strategy to identify and prevent premature cardiovascular disease: a feasibility pilot-studyPierre Charleux, Niki Procopi, Ghilas Rahoual, et al.
American Heart Journal|September 21, 2015
Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trialCyril Pellaton, Guillaume Cayla, Johanne Silvain, et al.
Progress in Cardiovascular Diseases|February 6, 2018
Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Usama Talib, Tarek Nafee, et al.
BMJ (Clinical Research Ed.)|May 9, 2015
Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysisAnne Bellemain-Appaix, Mathieu Kerneis, Stephen A O'Connor, et al.
Thrombosis and Haemostasis|December 7, 2017
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX TrialGerald Chi, Samuel Z Goldhaber, Russell D Hull, et al.
Archives of Cardiovascular Diseases|July 18, 2015
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary interventionGoran Loncar, Olivier Barthelemy, Emmanuel Berman, et al.
Journal of Clinical Medicine|March 7, 2020
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPaul Guedeney, Jules Mesnier, Sabato Sorrentino, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
European Heart Journal|November 10, 2011
High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET studyJohanne Silvain, Guillaume Cayla, Jean-Sébastien Hulot, et al.
Circulation. Cardiovascular Interventions|November 11, 2015
Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE studyStephen A O'Connor, Julien Amour, Anne Mercadier, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
European Journal of Preventive Cardiology|February 14, 2025
A family-based strategy to identify and prevent premature cardiovascular disease: a feasibility pilot-studyPierre Charleux, Niki Procopi, Ghilas Rahoual, et al.
American Heart Journal|September 21, 2015
Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trialCyril Pellaton, Guillaume Cayla, Johanne Silvain, et al.
Progress in Cardiovascular Diseases|February 6, 2018
Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Usama Talib, Tarek Nafee, et al.
BMJ (Clinical Research Ed.)|May 9, 2015
Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysisAnne Bellemain-Appaix, Mathieu Kerneis, Stephen A O'Connor, et al.
Thrombosis and Haemostasis|December 7, 2017
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX TrialGerald Chi, Samuel Z Goldhaber, Russell D Hull, et al.
Archives of Cardiovascular Diseases|July 18, 2015
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary interventionGoran Loncar, Olivier Barthelemy, Emmanuel Berman, et al.
Journal of Clinical Medicine|March 7, 2020
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPaul Guedeney, Jules Mesnier, Sabato Sorrentino, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
European Heart Journal|November 10, 2011
High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET studyJohanne Silvain, Guillaume Cayla, Jean-Sébastien Hulot, et al.
Circulation. Cardiovascular Interventions|November 11, 2015
Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE studyStephen A O'Connor, Julien Amour, Anne Mercadier, et al.
Pageof 15